Related references
Note: Only part of the references are listed.Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition
Jean-Michel Vallat et al.
LANCET NEUROLOGY (2010)
Differential effects of hydrocortisone and TNF alpha on tight junction proteins in an in vitro model of the human blood-brain barrier
Carola Foerster et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Glucocorticoid receptor physiology
Marjet D. Heitzer et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)
Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells
Sumio Ohtsuki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system
C Förster et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Medical progress:: Chronic inflammatory demyelinating polyneuropathy
H Köller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1
T Kanda et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis
J Schmidt et al.
BRAIN (2003)
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice
T Nitta et al.
JOURNAL OF CELL BIOLOGY (2003)
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy
R Hughes et al.
ANNALS OF NEUROLOGY (2001)
Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy
T Kanda et al.
NEUROLOGY (2000)
Share Paper
